Healthcare CEO Guide: What Your Board or Partners Must Decide Before LOI
Key Takeaways
- Board alignment before LOI protects leverage and credibility.
- Deal type changes control, economics, and post-close risk.
- Internal disagreements often become buyer-visible diligence issues.
- Headline price matters less than actual proceeds and terms.
- Clear decision rights reduce delay, confusion, and retrade pressure.
Why Alignment Must Happen Before LOI
An LOI should confirm a shared strategy, not expose internal conflict. In 2025, 47% of directors said M&A was a strategic priority for their boards, showing how early governance matters in real transactions. Buyers also test whether ownership is stable and organized, which is why partner disputes before selling should be addressed before serious negotiations begin.
Decide the Deal You Actually Want
Before any LOI, the board or partners must decide whether they want a full sale, recapitalization, or strategic partnership. That choice shapes price, control, rollover, and future obligations. MedBridge’s guidance on multiple exit scenarios fits here: a good deal is not always the highest headline offer. In healthcare, financial diligence also goes deeper because reimbursement, compliance, and reporting complexity can reshape value fast.
Price Is Not the Same as Proceeds
Many leadership teams focus too hard on valuation and too little on terms. Before LOI, partners should agree on what matters most: cash at close, rollover equity, governance rights, employment protection, or timing. That is where data quality, narrative consistency, and healthcare-specific diligence preparation start protecting value.
Control, Voting, and Sale Authority
Before LOI, partners must decide who can approve a deal, who can block one, and what level of consent is required. Buyers treat unclear authority as a governance risk, not a minor paperwork issue. That is why buy-in and buy-out conflicts should be resolved early. When voting thresholds, transfer restrictions, or deadlock rules are vague, a strong process can stall fast.
Assign One Internal Deal Leader
Boards often underestimate how much confusion comes from too many voices. Before signing an LOI, leadership should decide who owns diligence flow, who speaks to buyers, and who coordinates legal and financial advisors. A single internal lead helps management stay consistent, protects confidentiality, and prevents mixed answers. That is also why responding to buyer requests without appearing defensive is a practical pre-LOI issue, not just a communication detail.
Get Financial Definitions Straight Early
The board should also decide what financial story it is prepared to defend. That means agreeing on normalized EBITDA, supportable add-backs, expected working capital, and what counts as debt-like items. In healthcare, weak definitions can quietly change final proceeds even when the valuation looks strong on paper. Financial diligence often tests revenue quality, working capital trends, balance-sheet exposure, and reporting discipline more deeply than many sellers expect.
Decide What Can Be Shared and When
Healthcare sellers must decide early how diligence will handle PHI, cybersecurity, and confidentiality. HIPAA allows certain disclosures tied to due diligence and transactions, but that does not remove the need for disciplined process, limited access, and clear controls.^7 That is why managing cybersecurity and PHI risk in diligence should be settled before exclusivity begins.
Know When to Pause and When to Sign
Not every company is ready for an LOI just because buyer interest appears. Boards and partners should decide whether unresolved issues are manageable risks or true reasons to pause. Clean documentation, realistic valuation expectations, and process discipline often matter more than speed. That is why knowing when to pause a sale process matters before signing an LOI.
Why Buyers Reward Early Financial Clarity
Healthcare transactions tend to become more difficult when boards wait too long to clarify authority, financial definitions, and diligence boundaries. Buyers usually reward organizations that present a clean, consistent story supported by reliable reporting, realistic expectations, and disciplined governance. That is why financial diligence often becomes a decisive test of whether leadership truly understands earnings quality, working capital exposure, and balance-sheet risk before the LOI stage.
Why Process Discipline Protects Leverage
For healthcare CEOs, the goal is not simply to reach LOI quickly, but to enter it with fewer surprises and stronger leverage. Early alignment around governance, valuation expectations, confidentiality, and process discipline makes the transaction more credible from the start. That is also why avoiding deal fatigue with process discipline matters so much, especially when sellers want to protect momentum without losing control of the outcome.
Conclusion
A strong LOI process starts long before any document is signed. When boards and partners align early on strategy, authority, terms, financial definitions, and confidentiality, they protect leverage, reduce internal friction, and give buyers confidence that the deal can actually close. In healthcare M&A, the sellers who decide these issues before LOI are usually the ones who preserve value best.
FAQs
1. What should a board decide before signing an LOI?
The board should align on deal goals, acceptable valuation range, key terms, governance priorities, decision rights, and how much post-close involvement leadership is willing to keep.
2. Why do partner disagreements matter before LOI?
Because buyers see internal disagreement as transaction risk. Unclear authority, conflicting goals, or unresolved ownership issues can slow the process, weaken leverage, and create doubt about whether a deal can close smoothly.
3. Why is price not the same as proceeds?
Because the final outcome depends on more than headline valuation. Working capital adjustments, debt-like items, rollover equity, employment terms, and indemnity structure can all change what owners actually receive.
4. What financial issues should be settled before LOI?
Leadership should agree on normalized EBITDA, supportable add-backs, expected working capital, debt treatment, and the overall financial story the company can defend during diligence.
5. What confidentiality issues matter in a healthcare deal?
Healthcare sellers must decide how sensitive information, patient data, referral relationships, and internal communications will be protected during buyer discussions and diligence.